Gregory Renza
Stock Analyst at RBC Capital
(3.42)
# 967
Out of 5,008 analysts
221
Total ratings
40.84%
Success rate
6.69%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics | Maintains: Outperform | $31 → $35 | $102.17 | -65.74% | 3 | May 23, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Outperform | $26 | $21.54 | +20.71% | 16 | May 19, 2025 | |
| ADCT ADC Therapeutics | Reiterates: Outperform | $8 | $4.31 | +85.61% | 12 | May 15, 2025 | |
| INO Inovio Pharmaceuticals | Reiterates: Sector Perform | $5 | $2.39 | +109.21% | 11 | May 14, 2025 | |
| EXEL Exelixis | Reiterates: Outperform | $40 | $39.63 | +0.93% | 10 | May 14, 2025 | |
| ONC BeOne Medicines AG | Maintains: Outperform | $312 → $311 | $341.62 | -8.96% | 2 | May 8, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $182 → $172 | $137.32 | +25.25% | 14 | May 7, 2025 | |
| BCYC Bicycle Therapeutics | Maintains: Outperform | $35 → $32 | $8.00 | +300.00% | 3 | May 2, 2025 | |
| AMGN Amgen | Maintains: Outperform | $324 → $320 | $295.54 | +8.28% | 17 | May 2, 2025 | |
| CGON CG Oncology | Maintains: Outperform | $66 → $68 | $38.00 | +78.95% | 3 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $38 | $182.60 | -79.46% | 14 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $15 | $3.47 | +332.28% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $12 | $11.09 | +8.21% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $14 | $9.00 | +55.56% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $32 | $12.03 | +166.00% | 9 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $27 | $9.83 | +174.67% | 11 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $61 | $26.92 | +126.60% | 12 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $18 | $23.62 | -23.79% | 11 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $48 | $2.43 | +1,875.31% | 4 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $6 → $10 | $3.66 | +173.22% | 6 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $7 → $10 | $5.65 | +76.99% | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $47 | $21.00 | +123.81% | 11 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $57 | $40.87 | +39.47% | 6 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $4 | $9.24 | -56.71% | 3 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $110 → $20 | $4.61 | +333.84% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $16 | $0.84 | +1,813.19% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $2,160 → $180 | $13.48 | +1,235.31% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $80 | $1.45 | +5,417.24% | 5 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $105 → $30 | $0.76 | +3,847.37% | 3 | Jun 2, 2020 |
Cidara Therapeutics
May 23, 2025
Maintains: Outperform
Price Target: $31 → $35
Current: $102.17
Upside: -65.74%
ACADIA Pharmaceuticals
May 19, 2025
Reiterates: Outperform
Price Target: $26
Current: $21.54
Upside: +20.71%
ADC Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $8
Current: $4.31
Upside: +85.61%
Inovio Pharmaceuticals
May 14, 2025
Reiterates: Sector Perform
Price Target: $5
Current: $2.39
Upside: +109.21%
Exelixis
May 14, 2025
Reiterates: Outperform
Price Target: $40
Current: $39.63
Upside: +0.93%
BeOne Medicines AG
May 8, 2025
Maintains: Outperform
Price Target: $312 → $311
Current: $341.62
Upside: -8.96%
Jazz Pharmaceuticals
May 7, 2025
Maintains: Outperform
Price Target: $182 → $172
Current: $137.32
Upside: +25.25%
Bicycle Therapeutics
May 2, 2025
Maintains: Outperform
Price Target: $35 → $32
Current: $8.00
Upside: +300.00%
Amgen
May 2, 2025
Maintains: Outperform
Price Target: $324 → $320
Current: $295.54
Upside: +8.28%
CG Oncology
Apr 29, 2025
Maintains: Outperform
Price Target: $66 → $68
Current: $38.00
Upside: +78.95%
Apr 16, 2025
Maintains: Sector Perform
Price Target: $113 → $38
Current: $182.60
Upside: -79.46%
Mar 27, 2025
Maintains: Outperform
Price Target: $16 → $15
Current: $3.47
Upside: +332.28%
Mar 26, 2025
Reiterates: Outperform
Price Target: $12
Current: $11.09
Upside: +8.21%
Mar 21, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $9.00
Upside: +55.56%
Feb 27, 2025
Maintains: Outperform
Price Target: $34 → $32
Current: $12.03
Upside: +166.00%
Jan 29, 2025
Maintains: Outperform
Price Target: $26 → $27
Current: $9.83
Upside: +174.67%
Jan 15, 2025
Reiterates: Outperform
Price Target: $61
Current: $26.92
Upside: +126.60%
Jan 14, 2025
Reiterates: Sector Perform
Price Target: $18
Current: $23.62
Upside: -23.79%
Jan 9, 2025
Maintains: Outperform
Price Target: $68 → $48
Current: $2.43
Upside: +1,875.31%
Jan 7, 2025
Reiterates: Outperform
Price Target: $6 → $10
Current: $3.66
Upside: +173.22%
Dec 19, 2024
Upgrades: Outperform
Price Target: $7 → $10
Current: $5.65
Upside: +76.99%
Dec 17, 2024
Maintains: Outperform
Price Target: $44 → $47
Current: $21.00
Upside: +123.81%
Dec 10, 2024
Maintains: Outperform
Price Target: $55 → $57
Current: $40.87
Upside: +39.47%
Nov 14, 2024
Reiterates: Sector Perform
Price Target: $4
Current: $9.24
Upside: -56.71%
Nov 5, 2024
Downgrades: Sector Perform
Price Target: $110 → $20
Current: $4.61
Upside: +333.84%
Aug 14, 2024
Reiterates: Outperform
Price Target: $16
Current: $0.84
Upside: +1,813.19%
Jun 27, 2023
Downgrades: Sector Perform
Price Target: $2,160 → $180
Current: $13.48
Upside: +1,235.31%
Mar 16, 2022
Maintains: Sector Perform
Price Target: $100 → $80
Current: $1.45
Upside: +5,417.24%
Jun 2, 2020
Downgrades: Sector Perform
Price Target: $105 → $30
Current: $0.76
Upside: +3,847.37%